 BOSTON, June 01, 2022 GLOBE NEWSWIRE -- Atea Pharmaceuticals, Inc. Nasdaq: AVIR Atea, a clinical-stage biopharmaceutical company, today announced that Jean-Pierre Sommadossi, PhD, Chief Executive Officer and Founder of Atea Pharmaceuticals, will present a corporate overview and update at the Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 11:00 a.m. ET. 